This post was originally published on this site
Medtronic announced earnings per share of $1.32 on revenue of $7.85B. Analysts polled by Investing.com anticipated EPS of $1.29 on revenue of $7.98B.
Medtronic shares are down 0% from the beginning of the year, still down 13.98% from its 52 week high of $135.89 set on September 9. They are under-performing the S&P 500 which is up 24.68% from the start of the year.
Medtronic’s report follows an earnings beat by Pfizer on November 2, who reported EPS of $1.34 on revenue of $24.09B, compared to forecasts EPS of $1.08 on revenue of $22.58B.
Novo Nordisk ADR had beat expectations on November 3 with third quarter EPS of $0.8209 on revenue of $5.55B, compared to forecast for EPS of $0.7768 on revenue of $5.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
